Company

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals develops medicines for neurological disorders.

About

Founded in 1996 and based in British Columbia, Canada, Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for neurological disorders. Its pipeline includes XEN496, XEN1101, XEN007, NBI-921352 and FX301. The company trades on NASDAQ as XENE.

3Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in